Generium Is A Biopharmaceutical Company Based In Vladimirrussiaestablished In 2009It Specializes In Orphan Drugs And Biotechnological Products Aimed At Treating Rare Diseasesas A Full Cycle Biotech Firmgenerium Integrates Research And Developmentmanufacturingand Quality Control To Deliver Innovative Therapies For Severe Hereditary And Life Threatening Conditions The Company Operates A World Class Research Institute And Gmp Compliant Manufacturing Facilitiesgenerium S Services Include Comprehensive Drug Developmenthigh End Biologics Productionand Stringent Quality Control Processesits Product Lineup Features Treatments Such As Elizariaafor Paroxysmal Nocturnal Hemoglobinuriaglurazymeafor Gaucherae S Diseaseand Tigeraseafor Cystic Fibrosisgenerium Collaborates With Global Biotech Firms And Scientific Institutions To Enhance Drug Development And Primarily Serves The Russian And Cis Markets
